These independent CME activities are supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA LLC.



Clinical Context:
Diabetes
  1. Course List
Chair
Vivian A. Fonseca, MD, FRCP
  • Professor of Medicine and Pharmacology
  • Tullis Tulane Alumni Chair in Diabetes
  • Chief, Section of Endocrinology
  • Tulane University Health Sciences Center
  • New Orleans, Louisiana

  • Contributing Editor
    Cyrus V. Desouza, MD, MBBS
  • Professor and Chief
  • Department of Diabetes, Endocrinology and Metabolism
  • University of Nebraska Medical Center
  • Omaha, Nebraska

  • W. Timothy Garvey, MD
  • Professor and Chair
  • Department of Nutrition Sciences
  • University of Alabama at Birmingham
  • Birmingham, Alabama

  • Carla J. Greenbaum, MD
  • Director
  • Diabetes Clinical Research Program
  • Benaroya Research Institute at Virginia Mason
  • Seattle, Washington

  • Sandra M. Lord, MD
  • Clinical Research Associate
  • Diabetes Clinical Research Program
  • Benaroya Research Institutue at Virginia Mason
  • Seattle, Washington

  • Anne L. Peters, MD
  • Professor
  • University of Southern California
  • Keck School of Medicine
  • Director
  • USC Clinical Diabetes Program
  • Los Angeles, California
  • Disclosure Information
    Vivian A. Fonseca, MD, FRCP   has received honoraria from Abbott Laboratories, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, Inc, Pamlabs, Sanofi-aventis, and Takeda Pharmaceuticals; and has conducted contracted research for Abbott Laboratories, Asahi Kasei Pharma Corp., Eli Lilly and Company, Endo Barrier, Gilead Sciences, and Novo Nordisk, Inc.

    Cyrus V. Desouza, MD, MBBS   has received salary/honoraria from Takeda Pharmaceutical Company Limited; and consulting fees from Novo Nordisk.

    W. Timothy Garvey, MD   has received honoraria from LipoScience Inc and Merck & Co, Inc; has received consulting fees from Alkermes, Daiichi Sankyo Inc, Janssen Pharmaceuticals, Johnson & Johnson Inc, LipoScience Inc, and Vivus Inc; has conducted contracted research for Amylin Pharmaceuticals, Merck & Co, Inc, and Weight Watchers; and has ownership interest in Bristol-Myers Squibb, Eli Lilly and Company, Institute for Science and International Security, Merck & Co, Inc, Novartis Pharmaceuticals Corporation, Otsuka Pharmaceuticals, and Vivus Inc.

    Carla J. Greenbaum, MD   has received consulting fees from Bristol-Myers Squibb and has conducted contracted research for Janssen and Novo Nordisk.

    Sandra M. Lord, MD  

    Anne L. Peters, MD   has received salary/honoraria from AstraZeneca/Bristol-Myers Squibb and Novo Nordisk Pharmaceuticals, Inc.; and consulting fees from Abbott Diabetes Care, AstraZeneca/Bristol-Myers Squibb, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic MiniMed, Inc., Sanofi-Aventis, and Takeda Pharmaceutical Company Limited.